echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Am J Ophthalmol: Plasma arginine and citrulline increased in patients with type 2 diabetic retinopathy

    Am J Ophthalmol: Plasma arginine and citrulline increased in patients with type 2 diabetic retinopathy

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diabetic retinopathy (DR) is a progressive complication of diabetes and the main cause of blindness worldwide
    .


    The global prevalence of adult DR in 2015 was estimated at 415 million, and it is expected to rise to 642 million by 2042


    Diabetic retinopathy (DR) is a progressive complication of diabetes and the main cause of blindness worldwide


    DR progressed from a lighter non-proliferative phase (NPDR) to a more severe proliferative phase (PDR)


    Figure 1: Figure 1: Simplified description of the arginase and nitric oxide synthase pathways


    OAT = ornithine aminotransferase, AL = arginine succinate lyase, AS = arginine succinate synthase, ADMA = asymmetric dimethylarginine

    The purpose of this study is to identify 6 arginine and citrulline related metabolites (arginine, citrulline, asymmetric dimethylarginine [ADMA], ornithine, proline, and arginine Succinate) differs between patients with type 2 diabetic retinopathy (DR) and type 2 diabetes controls, or between patients with proliferative DR (PDR) and non-proliferative DR (NPDR)
    .

    The purpose of
    this study is to identify 6 arginine and citrulline related metabolites (arginine, citrulline, asymmetric dimethylarginine [ADMA], ornithine, proline, and arginine Succinate) differs between patients with type 2 diabetic retinopathy (DR) and type 2 diabetes controls, or between patients with proliferative DR (PDR) and non-proliferative DR (NPDR) .


    The purpose is to identify 6 arginine and citrulline related metabolites (arginine, citrulline, asymmetric dimethylarginine [ADMA], ornithine, proline, and arginine succinate Salt) There are differences between patients with type 2 diabetic retinopathy (DR) and type 2 diabetes controls, or between proliferative DR (PDR) and non-proliferative DR (NPDR)


    Design design design

    Cross-sectional study
    .


    Recruiting adult patients with type 2 diabetes from the Vanderbilt Eye Institute


    Cross-sectional study


    Result result result

    Figure 2 : Unadjusted analysis showed that compared with the diabetic control group, plasma arginine, citrulline, ADMA, ornithine and arginine succinate levels were significantly increased in DR patients, but there was no difference in proline levels
    .

    Figure 2 : Unadjusted analysis showed that compared with the diabetic control group, plasma arginine, citrulline, ADMA, ornithine and arginine succinate levels were significantly increased in DR patients, but there was no difference in proline levels
    .


    Figure 2 : Unadjusted analysis showed that compared with the diabetic control group, plasma arginine, citrulline, ADMA, ornithine and arginine succinate levels were significantly increased in DR patients, but there was no difference in proline levels


    Table 2 : In order to explain the potential confounding effects of demographic or clinical differences between groups, we performed a multivariate logistic regression analysis for each metabolite with retinopathy as the outcome, adjusted for age, gender, HbA1c, diabetes course, and statins The use of drug-like drugs or ACEI/ARB (Table 2)
    .


    In these regressions, DR patients had significantly higher levels of arginine (P = 0.


    Table 2 : In order to explain the potential confounding effects of demographic or clinical differences between groups, we performed a multivariate logistic regression analysis for each metabolite with retinopathy as the outcome, adjusted for age, gender, HbA1c, diabetes course, and statins The use of drug-like drugs or ACEI/ARB (Table 2)


    Table 3 : We repeated logistic regression analysis for the subgroups of patients who added creatinine as a covariate (Table 3), and found that after adjusting for multiple tests, compared with the diabetic control group, the arginine of DR patients (FDR adjusted P = 0.
    0067) and citrulline (FDR corrected P = 0.
    0025) levels were still significantly increased
    .

    Table 3 : We repeated logistic regression analysis for the subgroups of patients who added creatinine as a covariate (Table 3), and found that after adjusting for multiple tests, compared with the diabetic control group, the arginine of DR patients (FDR adjusted P = 0.
    0067) and citrulline (FDR corrected P = 0.
    0025) levels were still significantly increased
    .


    Table 3 Table 3We repeated logistic regression analysis for the subgroups of patients who added creatinine as a covariate (Table 3), and found that after adjusting for multiple tests, compared with the diabetic control group, the arginine of DR patients (FDR adjusted P = 0.
    0067) and citrulline (FDR corrected P = 0.
    0025) levels were still significantly increased
    .

    Figure 3 : In an unadjusted analysis, PDR patients (n=64) have higher plasma ADMA than NPDR patients (n=92)

    Figure 3 : In the unadjusted analysis, plasma ADMA of PDR patients (n=64) was higher than that of NPDR patients (n=92) Figure 3 : In the unadjusted analysis, plasma ADMA of PDR patients (n=64) was higher than NPDR Patient (n=92)Figure 3

    Table 4 : Multivariate logistic regression analysis controlling age, gender, HbA1c, diabetes course, statin use and ACEI/ARB use (Table 4) also showed that compared with NPDR patients, PDR patients had ADMA (P = 0.
    0051) Significant increase, including after adjustment for multiple testing (FDR adjusted P = 0.
    031)
    .

    Table 4 : Multivariate logistic regression analysis controlling age, gender, HbA1c, diabetes course, statin use and ACEI/ARB use (Table 4) also showed that compared with NPDR patients, PDR patients had ADMA (P = 0.
    0051) Significant increase, including after adjustment for multiple testing (FDR adjusted P = 0.
    031)
    .
    Table 4 : Multivariate logistic regression analysis controlling age, gender, HbA1c, diabetes course, statin use and ACEI/ARB use (Table 4) also showed that compared with NPDR patients, PDR patients had ADMA (P = 0.
    0051) Significant increase, including after adjustment for multiple testing (FDR adjusted P = 0.
    031)
    .
    Table 4

    As mentioned in the supplementary material, in order to explain the renal function in NPDR and PDR analysis, a logistic regression analysis was performed on a subset of DR patients with available creatinine data (n = 58 NPDR, n = 42 PDR)
    .
    In the smaller cohort where creatinine was added to the model, there was no longer a significant difference in ADMA between NPDR and PDR patients (OR = 1.
    30, 95% CI = 0.
    90-1.
    91, P = 0.
    15)
    .
    For comparison, logistic regression was also performed in a smaller cohort without creatinine as a covariate
    .
    A logistic regression analysis in a smaller cohort without creatinine showed a marginal difference in ADMA values ​​between NPDR and PDR patients (P = 0.
    051)
    .

    As mentioned in the supplementary material, in order to explain the renal function in NPDR and PDR analysis, a logistic regression analysis was performed on a subset of DR patients with available creatinine data (n = 58 NPDR, n = 42 PDR)
    .
    In the smaller cohort where creatinine was added to the model, there was no longer a significant difference in ADMA between NPDR and PDR patients (OR = 1.
    30, 95% CI = 0.
    90-1.
    91, P = 0.
    15)
    .
    For comparison, logistic regression was also performed in a smaller cohort without creatinine as a covariate
    .
    A logistic regression analysis in a smaller cohort without creatinine showed a marginal difference in ADMA values ​​between NPDR and PDR patients (P = 0.
    051)
    .
    As mentioned in the supplementary material, in order to explain the renal function in NPDR and PDR analysis, a logistic regression analysis was performed on a subset of DR patients with available creatinine data (n = 58 NPDR, n = 42 PDR)
    .
    In the smaller cohort where creatinine was added to the model, there was no longer a significant difference in ADMA between NPDR and PDR patients (OR = 1.
    30, 95% CI = 0.
    90-1.
    91, P = 0.
    15)
    .
    For comparison, logistic regression was also performed in a smaller cohort without creatinine as a covariate
    .
    A logistic regression analysis in a smaller cohort without creatinine showed a marginal difference in ADMA values ​​between NPDR and PDR patients (P = 0.
    051)
    .
    As mentioned in the supplementary material, in order to explain the renal function in NPDR and PDR analysis, a logistic regression analysis was performed on a subset of DR patients with available creatinine data (n = 58 NPDR, n = 42 PDR)
    .
    In the smaller cohort where creatinine was added to the model, there was no longer a significant difference in ADMA between NPDR and PDR patients (OR = 1.
    30, 95% CI = 0.
    90-1.
    91, P = 0.
    15)
    .
    In the smaller cohort with creatinine added to the model, there was no significant difference in ADMA between NPDR and PDR patients.
    For comparison, logistic regression was also performed in the smaller cohort without creatinine as a covariate
    .
    A logistic regression analysis in a smaller cohort without creatinine showed a marginal difference in ADMA values ​​between NPDR and PDR patients (P = 0.
    051)
    .

    in conclusion

    Conclusion Conclusion Conclusion

    This study showed that compared with the diabetic control group, the plasma arginine and citrulline of patients with type 2 diabetes with retinopathy increased
    .
    We also found that compared with NPDR patients, plasma ADMA in PDR patients was elevated, although this relationship was not significant in the subgroup of patients with creatinine values
    .
    This study confirms the importance of arginine and citrulline metabolism in DR, and emphasizes the need for future research on how these metabolites cause this debilitating disease
    .

    This study showed that compared with the diabetic control group, the plasma arginine and citrulline of patients with type 2 diabetes with retinopathy increased
    .
    We also found that compared with NPDR patients, plasma ADMA in PDR patients was elevated, although this relationship was not significant in the subgroup of patients with creatinine values
    .
    This study showed that compared with the diabetic control group, the plasma arginine and citrulline of patients with type 2 diabetes with retinopathy increased
    .
    We also found that compared with NPDR patients, plasma ADMA in PDR patients was elevated, although this relationship was not significant in the subgroup of patients with creatinine values
    .
    This study showed that compared with the diabetic control group, the plasma arginine and citrulline of patients with type 2 diabetes with retinopathy increased
    .
    We also found that compared with NPDR patients, plasma ADMA in PDR patients was elevated, although this relationship was not significant in the subgroup of patients with creatinine values
    .
    This study confirms the importance of arginine and citrulline metabolism in DR, and emphasizes the need for future research on how these metabolites cause this debilitating disease
    .
    This study confirms the importance of arginine and citrulline metabolism in DR, and emphasizes the need for future research on how these metabolites cause this debilitating disease
    .
    This study confirms the importance of arginine and citrulline metabolism in DR, and emphasizes the need for future studies on how these metabolites cause this debilitating disease.
    This study confirms the importance of arginine and citrulline.
    The importance of amino acid metabolism in DR and emphasizes the need for future research on how these metabolites cause this debilitating disease

     

    Original link: https://pubmed.
    ncbi.
    nlm.
    nih.
    gov/34587493/

    Original link: https://pubmed.
    ncbi.
    nlm.
    nih.
    gov/34587493/ https://pubmed.
    ncbi.
    nlm.
    nih.
    gov/34587493/

    Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy

    Arginine and Citrulline are Elevated Plasma in Diabetic Retinopathy Plasma Arginine and Citrulline are Elevated in Diabetic Retinopathy in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.